Impact Evaluation of Benazir Nashonuma Program (BNP) on Stunting Among Under-five Children
Impact Assessment of Benazir Nashonuma Program (BNP) on Stunting Prevention Among Children 0-59 Months of Age in Pakistan
1 other identifier
interventional
13,200
1 country
1
Brief Summary
The aim of the study is to evaluate the impact of Benazir Nashonuma Program (BNP) on prevalence of stunting among under-five children in low income setting of Pakistan. The research question that the study aims to answer is: Is there any change in the prevalence of stunting among under-five children in districts where Benazir Nashonuma Program (BNP) is established compared to districts where BNP is not established? Districts where BNP is functional, and women and children are receiving the intervention will be compared at baseline and end line with control districts where conventional reproductive care services are given. Prevalence of stunting among under-five children will be compared along with other nutritional and growth status indicators over a period of 4 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 16, 2023
CompletedFirst Posted
Study publicly available on registry
September 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedSeptember 11, 2023
July 1, 2023
4.1 years
August 16, 2023
September 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Baseline to end-line change in the prevalence of stunting among children 0-59 months of age
Height-for-age ≤-2 SD of the WHO Child growth standards median
3 years (on study completion)
Secondary Outcomes (10)
Baseline to end-line change in the prevalence of underweight women of reproductive age (15-49 years)
3 years (on study completion)
Baseline to end-line change in the prevalence of wasting among children 0-59 months of age
3 years (on study completion)
Baseline to end-line change in the prevalence of food insecurity status at household level
3 years (on study completion)
Baseline to end-line change in the number of antenatal care (ANC) visits during pregnancy
3 years (on study completion)
Baseline to end-line change in the prevalence of institutional deliveries
3 years (on study completion)
- +5 more secondary outcomes
Study Arms (2)
Districts with established and operational BNP implementation
EXPERIMENTALThe intervention arm consists of nine districts from four provinces and two regions of Pakistan where the Benazir Nashonuma Program (BNP) is operational, providing reproductive and healthcare services to pregnant women and their children under the age of two.
Districts without BNP implementation and functionality
NO INTERVENTIONThe control arm comprises of nine districts where Benazir Nashonuma Program (BNP) has not been implemented. These districts are comparable to their respective intervention districts in terms of average maternal BMI and prevalence of stunting.
Interventions
Benazir Nashonuma Program (BNP) Dietary supplement for pregnant women and lactating mothers during the first six months of lactation: Maamta is a 75-gram sachet made from peanut butter with 400 kcal of energy Dietary supplement for children aged 6-23 months: Wawamum is a lipid-based nutrient supplement consisting of skimmed milk powder, micronutrients, vegetable oil, roasted chickpeas and antioxidants. Wawamum covers the recommended daily dose of most micronutrients and 255 kcal of energy. Conditional Cash Transfer (CCT): This includes stipends of PKR 2000 during pregnancy contingent on three antenatal care visits, consuming SNF, attending awareness sessions on health and nutrition, getting two doses of tetanus toxoid and institutional delivery. After delivery PKR 2000/- for boys and 2500/- for girls are paid as incentives conditioned on getting child's birth registered, routine immunization and consumption of SNF by the child from 6-23 months
Eligibility Criteria
You may not qualify if:
- Mother of the child who is not a woman of reproductive age, i.e., less than 15 years or greater than 49 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aga Khan Universitylead
- International Food Policy Research Institutecollaborator
- Bill and Melinda Gates Foundationcollaborator
Study Sites (1)
Aga Khan University
Karachi, Sindh, 75290, Pakistan
Related Publications (1)
Muhammad S, Malik AA, Soofi S, Habib A, Umer M, Rizvi A, Ahmed I, Leroy J, Cousens S, Bhutta ZA. Impact assessment of Benazir Nashonuma Programme (BNP) on maternal, child health and nutritional status in Pakistan: a quasi-experimental study protocol. BMJ Open. 2025 Jun 27;15(6):e094565. doi: 10.1136/bmjopen-2024-094565.
PMID: 40578861DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zulfiqar A Bhutta, PhD, FRC
Aga Khan University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Distinguished University Professor and Founding Director of the Institute for Global Health and Development and the Centre of Excellence in Women and Child Health
Study Record Dates
First Submitted
August 16, 2023
First Posted
September 6, 2023
Study Start
December 1, 2021
Primary Completion
December 20, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
September 11, 2023
Record last verified: 2023-07